Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.35 |
| ▸ | GABRP | O00591 | 2/20 | 0.31 |
| ▸ | GABRD | O14764 | 2/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.31 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.31 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.31 |
| ▸ | GABRE | P78334 | 2/20 | 0.31 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.31 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.31 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.31 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27881916 | 0.97 | TP53 (0.40) | TP53FFAR3CYP1A2SLC7A5 | |
| SCHEMBL9419623 | 0.92 | TP53 (0.36) | TP53FFAR3CYP1A2SLC7A5TSHR | |
| SCHEMBL17654220 | 0.86 | TP53 (0.36) | TP53FFAR3CYP1A2SLC7A5TSHR | |
| SCHEMBL9250585 | 0.82 | CYP1A2 (0.39) | TP53FFAR3CYP1A2GABRPGABRD | |
| SCHEMBL8712260 | 0.81 | TP53 (0.42) | TP53CYP1A2SLC7A5GABRR1RNPEP | |
| SCHEMBL6296205 | 0.79 | — | — | |
| SCHEMBL225761 | 0.79 | — | — | |
| SCHEMBL28738930 | 0.77 | — | — | |
| SCHEMBL17622448 | 0.77 | — | — | |
| SCHEMBL28445868 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4634304-A1 | MODIFIED ASPHALT COMPOSITIONS CONTAINING VINYL ACETATE LATEXES AND METHODS FOR MAKING SAME | BASF SE (DE) | 2025-10-22 | — | — | EP | disclosed |
| US-20250171641-A1 | COATINGS CONTAINING CLOSED-CELL METAL OXIDE PARTICLES | BASF CORPORATION | 2025-05-29 | — | — | US | disclosed |
| US-12286757-B2 | Aqueous compositions with improved barrier properties | BASF SE (DE) | 2025-04-29 | — | — | US | disclosed |
| US-20250109298-A1 | ELECTROMAGNETIC RADIATION MITIGATION IN COATINGS WITH SPHERICAL PARTICLES | BASF SE (DE) | 2025-04-03 | — | — | US | disclosed |
| US-20250109300-A1 | COATINGS CONTAINING HYBRID METAL OXIDE PARTICLES | BASF SE (DE) | 2025-04-03 | — | — | US | disclosed |
| US-12219954-B2 | Aqueous dispersion of a pesticide and polymer particles containing a copolymerizable surfactant | BASF SE (DE) | 2025-02-11 | — | — | US | disclosed |
| US-20240400454-A1 | Antimicrobial Coating for Building Panel | BANK OF AMERICA, N.A., AS COLLATERAL AGENT | 2024-12-05 | — | — | US | disclosed |
| EP-4466316-A1 | COATINGS CONTAINING HYBRID METAL OXIDE PARTICLES | BASF SE (DE) | 2024-11-27 | — | — | EP | disclosed |
| EP-4466317-A1 | COATINGS CONTAINING CLOSED-CELL METAL OXIDE PARTICLES | BASF SE (DE) | 2024-11-27 | — | — | EP | disclosed |
| US-20240359429-A1 | Gypsum Panel Having Enhanced Hail Resistance | BANK OF AMERICA, N.A., AS COLLATERAL AGENT | 2024-10-31 | — | — | US | disclosed |
| US-20030018137-A1 | Method for producing a polymeric conversion product | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-23 | — | — | US | disclosed |
| US-6506836-B1 | Reacting under free-radical conditions a reaction mixture comprising at least one free-radically reactable monomer (a) in the presence of at least one free-radical initiator and of a compound process for preparing a polymer using said reaction | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-14 | — | — | US | disclosed |
| US-6486245-B1 | Self-arranging coating | NANOGATE TECHNOLOGIES GMBH (DE) | 2002-11-26 | — | — | US | disclosed |
| US-6262159-B1 | FOR USE AS BINDERS FOR TEXTILE SHEETLIKE STRUCTURES AND FOR MOLDINGS | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-17 | — | — | US | disclosed |
| US-5863956-A | Mesomorphic complexes of polyelectrolytes and surfactants, process for producing the same and films, foils, fibers, molded bodies and coatings made thereof | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-26 | — | — | US | disclosed |
| EP-0313407-B1 | Method for preparing polyimide and composite material thereof | MITSUI TOATSU CHEMICALS (JP) | 1996-05-08 | — | — | EP | disclosed |
| US-5043419-A | Reacting an aromatic diamine, a tetracarboxylic dianhydride, and a dicarboxylic anhydride; molded products for air and space craft; heat resistant; mechanical strength | MITSUI TOATSU CHEMICALS, INC. (JP) | 1991-08-27 | — | — | US | disclosed |
| US-4937316-A | Process for preparing polyimides | AMDAHL CORPORATION (US) | 1990-06-26 | — | — | US | disclosed |
| EP-0330505-A1 | Process for preparing polyimides | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-30 | — | — | EP | disclosed |
| EP-0313407-A2 | Method for preparing polyimide and composite material thereof | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12219954-B2 | Aqueous dispersion of a pesticide and polymer particles containing a copolymerizable surfactant | DDT, PLD1, NAPEPLD | TP53 76/4885FFAR3 2484/4885CYP1A2 1607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.